CD8A and neoplasm: In a CD8+ antitumoral reponse, antigens can be acquired in the tumor by phagocytic cells, then transported to secondary lymphoid organs and cross presented to prime CD8+ T cells after which activated CD8+ cells migrate to inflammation sites and ideally kill cells that present the antigen.